You don't have permission to view this recording. Please log in or use your personalized link.
About
In today’s R&D landscape, breakthrough science isn’t just about inventing new tools, it’s about scaling those innovations across increasingly complex environments.

This Digital Dialogue will explore how automation is transforming scientific operations at every level. From hands-on robotics that accelerate individual experiments to enterprise-wide platforms that process thousands of samples each month, the session will showcase how leading organizations are leveraging automation to drive both innovation and impact at scale.

You’ll gain insights into how curiosity-driven engineering is driving lab-level innovation, with a focus on novel analytical workflows that push the boundaries of discovery. Building on this, the session will showcase a case study from Thermo Fisher Scientific and Merck that demonstrates how these innovations can be scaled across the enterprise—addressing the complex challenges of automation, data integration, and operational efficiency.
Presenters
1746703811-685f12da8690162c
Johannes Rajarao, PhD
Sr. Director for Regulated Robotics and Data at Merck Vaccines
Johannes Rajarao is Sr. Director for Regulated Robotics and Data, Merck Vaccines, where he leads the assay automation and data management capability for regulated bioanalytical testing. Prior to joining Merck, Dr. Rajarao led digital transformation programs at Accenture Lifesciences and before that, lab informatics provider, IDBS.
1746704022-1de616ad969862aa
Hansjoerg Haas, PhD
Senior Director and General Manager, Laboratory Automation, Thermo Fisher Scientific
Hansjoerg Haas serves as Senior Director and General Manager of the Laboratory Automation business at Thermo Fisher Scientific. With a distinguished career spanning over 30 years, Dr. Haas has been a key advocate for advancing laboratory automation solutions for the pharmaceutical, biopharmaceutical, and academic sectors.
1747059976-5cc65f0aa49c887d
David Chang-Yen, PhD
Senior Principal Research Scientist, AbbVie
David Chang-Yen is a Senior Principal Research Scientist at AbbVie, where he has been a member of the SPaRCS (Specialized Research in Chaotic Systems) group for 15 years. During his tenure at AbbVie he has developed many systems in support of Discovery Research projects, including automated prep systems for NMR spectroscopy, custom medicinal chemistry exploration platforms, and high-throughput mass spectroscopy sample delivery.
1730389266-23ebbb44762db841
Joshua Lally
Conference Producer, Lab of the Future
Register To Watch Recording
First Name*
Last Name*
Email Address*
Job Title*
Company*
Country*
Privacy and Data Policy
Open Pharma Research Ltd will use the information you provide on this form to enable access to Lab of the Future; Digital Dialogue live events and provide information on Lab of the Future Congress. We will not share your contact details with anyone else nor sell your personal information. You can unsubscribe anytime by clicking the unsubscribe link in the footer of our emails, or by replying to our emails and asking to be unsubscribed.
Yes, I consent*
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.